Nano Labs director Hu Nan sold 11,165 shares across seven transactions priced from $2.22 to $2.31 per share on 2026-09-01. The post-sale holding was 27,651 shares, giving investors a precise view of the director’s reported ownership after the transactions.
Key Highlights
- Hu Nan’s Nano Labs holdings stood at 27,651 shares after the transactions.
- The sale was divided across seven separate transactions.
- Prices ranged from $2.22 to $2.31 per share.
Nano Labs Ltd (NASDAQ: NA) director Hu Nan sold 11,165 shares at prices ranging from $2.22 to $2.31 per share.
Seven Transactions Completed on 1 September 2026
The sales took place on 1 September 2026 and were divided among seven separate transactions. Each transaction carried code S. The reported price range began at $2.22 per share and extended to $2.31 per share. Hu Nan’s remaining ownership was recorded at 27,651 shares following completion of the transactions. The reported activity covers Nano Labs Ltd shares sold by a director in separate transactions on the same date. The post-transaction ownership figure applies after all seven sales were completed.
Peers Moving on This News
FAQs
Q: How many Nano Labs shares did Hu Nan sell?
A: Nano Labs director Hu Nan sold 11,165 shares across seven separate transactions. The sales were completed on 1 September 2026 at prices ranging from $2.22 to $2.31 per share.
Q: What was the impact of Hu Nan’s Nano Labs share sale?
A: Hu Nan’s reported Nano Labs ownership stood at 27,651 shares after the transactions. The disclosed activity records a director share sale at specified per-share prices.
Q: How many Nano Labs shares does Hu Nan still own?
A: Hu Nan owned 27,651 Nano Labs shares after completing the transactions. The reported post-sale figure follows seven sales made on 1 September 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.